Article
KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics.
The Journal of molecular diagnostics : JMD - 1 May 2013
Rechsteiner Markus, von Teichman Adriana, Rüschoff Jan H, Fankhauser Niklaus, Pestalozzi Bernhard, Schraml Peter, Weber Achim, Wild Peter, Zimmermann Dieter, Moch Holger
Abstract excerpt
In colorectal carcinoma, KRAS (alias Ki-ras) and BRAF mutations have emerged as predictors of resistance to anti-epidermal growth factor receptor antibody treatment and worse patient outcome, respectively. In this study, we aimed to establish a high-throughput deep sequencing workflow according to 454 pyrosequencing technology to cope with the increasing demand for sequence information at medical institutions. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
